GlassScriptPhysician profile
William Andrew Parker
NPI 1790946333
$1,308.11
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $898 · 2020: $122 · 2021: $17.68 · 2022: $249 · 2023: $20.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $337.32 | 2019 | |
| Glaxosmithkline, LLC. | $301.62 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.32 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $102.63 | 2019-2023 | Imfinzi |
| Pfizer INC. | $56.00 | 2019-2020 | |
| Philips North America LLC | $54.81 | 2019 | |
| Sanofi-Aventis U.S. LLC | $42.83 | 2019-2021 | |
| Shire North American Group INC | $27.12 | 2019 | |
| Grifols USA, LLC | $25.00 | 2019 | |
| Genzyme Corporation | $21.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.74 | 2019 | |
| Bioventus LLC | $18.74 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.04 | 2022 | |
| Sunovion Pharmaceuticals INC. | $15.56 | 2020 | |
| Genentech USA, INC. | $15.44 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $15.30 | 2022 | |
| Mylan Specialty L.P. | $14.72 | 2020 | |
| Lilly USA, LLC | $14.53 | 2019 | |
| Gilead Sciences, INC. | $13.79 | 2019 | |
| Pacira Therapeutics, INC. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.